Operating Expenses
Total Lease Cost
Vertex Pharmaceuticals Total Lease Cost remained flat by 0.0% to $64.38M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 27.5%, from $50.50M to $64.38M. Over 2 years (FY 2023 to FY 2025), Total Lease Cost shows an upward trend with a 22.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026
How to read this metric
Provides a clear view of the total operational burden of leasing; rising costs relative to revenue may indicate declining efficiency.
Detailed definition
The comprehensive sum of all lease-related expenses, including operating lease costs, finance lease interest, and variab...
Peer comparison
Used by analysts to normalize operating expenses across companies with different capital structures.
Metric ID:
ibm_total_lease_costHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $171.20M | $202.00M | $257.50M |
| YoY Change | — | +18.0% | +27.5% |
Range$171.20M – $257.50M
CAGR+22.6%
Avg YoY Growth+22.7%
Median YoY Growth+22.7%
Current Streak2+ years growth
Total Lease Cost at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's total lease cost?
- Vertex Pharmaceuticals (VRTX) reported total lease cost of $64.38M in Q4 2025.
- How has Vertex Pharmaceuticals's total lease cost changed year-over-year?
- Vertex Pharmaceuticals's total lease cost increased by 27.5% year-over-year, from $50.50M to $64.38M.
- What is the long-term trend for Vertex Pharmaceuticals's total lease cost?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's total lease cost has grown at a 22.6% compound annual growth rate (CAGR), from $171.20M to $257.50M.
- What does total lease cost mean?
- The total cost of all lease obligations combined.